HR. 5629In Committee
To provide that the final rule of the Department of Health and Human Services titled "Medications for the Treatment of Opioid Use Disorder", except for the portion of the final rule relating to accreditation of opioid treatment programs, shall have no force or effect.
Nullifies most of the HHS opioid use disorder treatment rule, ending telehealth admissions and expanded methadone take-home flexibilities while preserving accreditation provisions
Plain-English overview
What this bill does
Nullifies most of the HHS opioid use disorder treatment rule, ending telehealth admissions and expanded methadone take-home flexibilities while preserving accreditation provisions
Key points
- Repeal telehealth admission flexibilities
- Repeal expanded methadone take home rules
- Repeal relaxed opioid treatment admission criteria
Current status
Where it stands
Status
In Committee
Latest action
2025-09-30 — Referred to the House Committee on Energy and Commerce.
Related context
Topics and policy areas
undefinedHealth